New Biomarker Predicts Non-Lymphocytic Lesions in Central Diabetes Insipidus Patients
Researchers show that patients with central diabetes insipidus who lack anti-rabphilin-3A antibodies could be at risk of tumor development
Read MorePosted by Andy Lundin | Nov 8, 2023 | Diabetes & Metabolic Diseases |
Researchers show that patients with central diabetes insipidus who lack anti-rabphilin-3A antibodies could be at risk of tumor development
Read MorePosted by Andy Lundin | Nov 3, 2023 | Kidney Disease |
Investigators developed an automated health maintenance tool to prompt physicians to screen for chronic kidney disease in diabetes patients.
Read MorePosted by Andy Lundin | Oct 18, 2023 | Diabetes & Metabolic Diseases |
Determining whether a person is diabetic could be as easy as having them speak a few sentences into their smartphone, a new study found.
Read MorePosted by Andy Lundin | Oct 4, 2023 | Diabetes & Metabolic Diseases |
Adding screening for type 2 diabetes in accident and emergency departments could uncover thousands of previously undiagnosed cases every year.
Read MorePosted by Andy Lundin | Aug 21, 2023 | Cardiovascular, Kidney Disease |
A simple blood test may predict the risk of progressive heart and kidney disease in people with Type 2 diabetes and kidney disease.
Read More